Sitemap

Home

About Us

About Us

Management

Board of Directors

Our Science

Our Science

Bacteriophages for Human Health

Product Pipeline

Product Pipeline

BioPhage-PA / Otitis

BioPhage-PR / Cystic Fibrosis

Other Applications

Hospital Acquired Infections

Burns

Veterinary Applications

Partners

Partners

Current Collaborations

Legacy Programs/Partners

Business Opportunities

News & Events

AmpliPhi Biosciences Announces UK Grant Award to develop its Novel Antimicrobial Technology

Targeted Genetics Announces Name Change to AmpliPhi Biosciences and Highlights Strategic Development

Scientists Explore Alternative to Antibiotics

Edison Investment Research releases “Antibiotic Amplifier”, an assessment of AmpliPhi Biosciences

AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York

AmpliPhi Biosciences appoints Philip J. Young as President and CEO

AmpliPhi Biosciences Announces First Closing of $2.7m

BioWorld Today features AmpliPhi CEO Phil Young

January 2012 Shareholder Letter

Investor Relations

Investor Relations

Contact Us

Contact

Miscellaneous

Privacy Policy

Terms and Conditions

Sitemap

Latest News

January 31st 2012

January 2012 Shareholder Letter

January 04th 2012

BioWorld Today features AmpliPhi CEO Phil Young

November 21st 2011

AmpliPhi Biosciences Announces First Closing of $2.7m

November 08th 2011

AmpliPhi Biosciences appoints Philip J. Young as President and CEO

September 06th 2011

AmpliPhi Biosciences to Present at Rodman & Renshaw Annual Global Investment Conference in New York